2438 Results for "

decrease

" in MedChemExpress (MCE) Product Catalog:
Products (2438)

2438 Results for "decrease" in MCE Product Catalog:

1
1 Cited Publications
Art. -Nr.: HY-P5521
CAS. Nr.: 3033299-76-9
Target:  

Inhibitory Antibodies

Forschungsgebiete:  

Cardiovascular Disease

mLR12 is a Trem1 inhibitory peptide. mLR12 decreases aortic rupture rate in BAPN-induced Thoracic aortic aneurysm and dissection (TAAD) mice model .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-130321
CAS. Nr.: 6919-91-1
Reinheit:  ≥98.0%
Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B0259
CAS. Nr.: 26807-65-8
Target:  

Potassium Channel

Forschungsgebiete:  

Cardiovascular Disease

Indapamide is an orally active sulphonamide diuretic agent, that can reduce blood pressure by decreasing vascular reactivity and peripheral vascular resistance. Indapamide is also can reduce left ventricular hypertrophy .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-135761
CAS. Nr.: 66246-88-6
Reinheit:  98.91%
Penconazole is a typical triazole fungicide, and mainly applied on apples, grapes, and vegetables to control powdery mildew. Penconazole inhibits sterol biosynthesis in fungi. Penconazole decrease AChE activity in the cerebrum and cerebellum of rats .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-138208
CAS. Nr.: 114014-15-2
Reinheit:  98.04%
Target:  

Cathepsin SARS-CoV

Forschungsgebiete:  

Infection

Z-Phe-Tyr(tBu)-diazomethylketone is a potent cathepsin L inhibitor. Z-Phe-Tyr(tBu)-diazomethylketone mediates reovirus disassembly. Z-Phe-Tyr(tBu)-diazomethylketone decreases viral detection .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-147041
CAS. Nr.: 1978336-95-6
Reinheit:  98.87%
Synonyms: GB1211
Target:  

Galectin

Forschungsgebiete:  

Inflammation/Immunology Cancer

Selvigaltin (GB1211) is an orally active galectin-3 small molecule inhibitor with an IC50 value of 12 nM in rabbits, showing anti-tumor activity. Selvigaltin decreases galectin-3 levels in the liver and reduces biomarkers of liver function (AST, ALT, bilirubin), inflammation (cells foci) and fibrosis (PSR, SHG), as well as decreasing the mRNA and protein expression of several key inflammation and fibrosis biomarkers (IL6, TGFβ3, SNAI2, collagen). Selvigaltin restores T-cell activity and induces less tumors and metastasis .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-13619
CAS. Nr.: 131179-95-8
Reinheit:  99.94%
Synonyms: RSR13
Target:  

Hemoglobin

Forschungsgebiete:  

Infection Cancer

Efaproxiral (RSR13) is a haemoglobin (Hb) synthetic allosteric modifier. Efaproxiral decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-13619A
CAS. Nr.: 170787-99-2
Reinheit:  99.90%
Synonyms: RSR13 sodium
Target:  

Hemoglobin

Forschungsgebiete:  

Infection Cancer

Efaproxiral (RSR13) sodium is a haemoglobin (Hb) synthetic allosteric modifier. Efaproxiral sodium decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-146985
CAS. Nr.: 2418577-51-0
Reinheit:  99.62%
Target:  

Cathepsin

Forschungsgebiete:  

Neurological Disease Cancer

Cathepsin X-IN-1 (compound 25) is a potent Cathepsin X inhibitor with an IC50 of 7.13 µM. Cathepsin X-IN-1 decreases PC-3 cell migration with low cytotoxic .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-119146
CAS. Nr.: 31352-82-6
Synonyms: CI-716 free base
Target:  

Drug Derivative

Forschungsgebiete:  

Neurological Disease

Zolazepam (CI-716 free base) is a benzodiazepine derivative with anxiolytic and anticonvulsant properties. Zolazepam combined with Tiletamine causes a decrease in ventilation, resulting in the development of respiratory acidosis. Zolazepam can be used as sedative and muscle relaxants .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-N2113
CAS. Nr.: 80508-81-2
Glaucocalyxin B is an ent kaurane diterpenoid isolated from the Chinese traditional medicine Rabdosia japonica with anticancer and antitumor activity; decreases the growth of HL-60 cells with an IC50 of approximately 5.86 μM at 24 h.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-104006
CAS. Nr.: 1069498-96-9
Reinheit:  99.12%
Target:  

Opioid Receptor

Forschungsgebiete:  

Neurological Disease

CYM51010 is a biased ligand of μ-opioid receptor – δ-opioid receptor heterodimers with an EC50 of 403 nM. CYM51010 exhibits anti-nociceptive activity similar to morphine but with a decreased levels of tolerance development and withdrawal symptoms .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-100775
CAS. Nr.: 1254472-97-3
Reinheit:  99.78%
Synonyms: Setogepram sodium; PBI-4050 sodium
Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras sodium decreases renal, liver and pancreatic fibrosis . Fezagepras sodium exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-100775A
CAS. Nr.: 1002101-19-0
Reinheit:  99.38%
Synonyms: Setogepram; PBI-4050
Fezagepras (Setogepram) acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras decreases renal, liver and pancreatic fibrosis . Fezagepras exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-120034
CAS. Nr.: 1462267-07-7
Reinheit:  99.53%
Forschungsgebiete:  

Neurological Disease Metabolic Disease

NCGC 607 is a noninhibitory small-molecule chaperone of glucocerebrosidase (GCase). NCGC 607 can increase GCase activity, reduce α-synuclein levels, and decrease glycolipid levels. NCGC 607 can be used in the research of Gaucher disease and Parkinson's disease .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-P3585
CAS. Nr.: 915091-83-7
Target:  

TNF Receptor

Epobis, a dendrimeric peptide, is a recombinant form of erythropoietin. Epobis is a potent erythropoietin receptor agonist. Epobis promotes neuritogenesis in primary motoneurons. Epobis decrease TNF release and crosses the blood-brain barrier. Epobis has anti-inflammatory and memory enhancing properties .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-13033
CAS. Nr.: 1269815-17-9
Reinheit:  98.97%
Synonyms: CDK inhibitor II
Target:  

CDK

Forschungsgebiete:  

Endocrinology

CDK-IN-2 is a specific CDK9 inhibitor with an IC50 of less than 8 nM. CDK-IN-2 reduces the phosphorylation level of H3S10. CDK-IN-2 decreases the transition rate of spermatocytes from prophase to metaphase I .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-153728
CAS. Nr.: 2894832-05-2
Reinheit:  98.74%
Target:  

WDR5

Forschungsgebiete:  

Cancer

WM-586 is a covalent WDR5 inhibitor. WM-586 specifically decreases WDR5 and MYC interaction with an IC50 of 101 nM. WM-586 is used in research on a variety of cancers including neuroblastoma, breast cancer, bladder cancer and colorectal cancer .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-15841
CAS. Nr.: 1391712-60-9
Reinheit:  99.91%
Forschungsgebiete:  

Cancer

CEP-37440 is a potent, orally active dual FAK/ALK inhibitor with IC50 values of 2.3 nM and 3.5 nM for FAK and ALK, respectively. CEP-37440 decreases the cell proliferation by blocking the autophosphorylation kinase activity of FAK1 (Tyr 397) .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-17556S1
Synonyms: Leucovorin-d4 calcium hydrate; Calcium folinate-d4 hydrate
Folinic acid-d4-1 (Leucovorin-d4-1) calcium hydrate is deuterated labeled Folinic acid (HY-17556). Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (HY-14519) as a rescue agent to decrease Methotrexate-induced toxicity.
loading...
    loading...